echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Cardiovasc Diabetol: High pericoronary adipose tissue density on CT angiography predicts cardiovascular events in patients with type 2 diabetes

    Cardiovasc Diabetol: High pericoronary adipose tissue density on CT angiography predicts cardiovascular events in patients with type 2 diabetes

    • Last Update: 2022-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background: Coronary artery disease (CAD) is the leading cause of death in patients with type 2 diabetes mellitus (T2DM)


    Background: Coronary artery disease (CAD) is the leading cause of death in patients with type 2 diabetes mellitus (T2DM)


    Recently, changes in peri-coronary adipose tissue (PCAT) attenuation assessed on coronary CTA were introduced as a new indicator of inflammation


    Objective: This study aimed to investigate the predictive value of PCAT reduction on prognosis in patients with type 2 diabetes mellitus (T2 DM)


    Methods: 333 T2 DM patients (average age 66 years old, 211 males, average body mass index 25 kg/m2) underwent coronary CTA examination to examine coronary calcium score, pericardial fat volume, stenosis degree (luminal stenosis>50 %), plaque hypodense and/or high-risk plaque features with positive remodeling and/or punctate calcification, and PCAT attenuation


    RESULTS: During a median follow-up of 4.


    Figure 1 Typical case of peri-coronary adipose tissue attenuation measured by coronary CT angiography


    Figure 1 Typical case of peri-coronary adipose tissue attenuation measured by coronary CT angiography


    Figure 2 Kaplan-Meier curves for cumulative incidence of cardiovascular events


    Figure 2 Kaplan-Meier curves for cumulative incidence of cardiovascular events


    Table 1 Factors associated with cardiovascular events

    Figure 3 Incremental prognostic value of left anterior descending artery-pericoronary adipose tissue attenuation for predicting cardiovascular events compared with adverse coronary CTA findings


    Figure 3 Incremental prognostic value of left anterior descending artery-pericoronary adipose tissue attenuation for predicting cardiovascular events compared with adverse coronary CTA findings


    Conclusions: In patients with T2 DM who underwent clinically diagnosed coronary CTA, high density of LAD-PCAT significantly predicted cardiovascular events


    Original source: Ichikawa K, Miyoshi T, Osawa K, et al.
    High pericoronary adipose tissue attenuation on computed tomography angiography predicts cardiovascular events in patients with type 2 diabetes mellitus: post-hoc analysis from a prospective cohort study.
    Cardiovasc Diabetol 2022 Mar 18 ;21(1) High pericoronary adipose tissue attenuation on computed tomography angiography predicts cardiovascular events in patients with type 2 diabetes mellitus: post-hoc analysis from a prospective cohort study.
    Leave a

    comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.